Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients

Mark R. Hanudel; Isidro B. Salusky; Renata C. Pereira; Wei Wang; Zhiying You; Kristen L. Nowak; Godela M. Brosnahan; Vicente E. Torres; Arlene B. Chapman; Ronald D. Perrone; Theodore I. Steinman; Kyongtae T. Bae; Berenice Y. Gitomer; Michel B. Chonchol

doi:10.1016/j.ekir.2019.08.010

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients

Mark R. Hanudel, Isidro B. Salusky, Renata C. Pereira, Wei Wang, Zhiying You, Kristen L. Nowak, Godela M. Brosnahan, Vicente E. Torres, Arlene B. Chapman, Ronald D. Perrone, Theodore I. Steinman, Kyongtae T. Bae, Berenice Y. Gitomer, Michel B. Chonchol

Nephrology and Hypertension

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1742-1748
Number of pages	7
Journal	Kidney International Reports
Volume	4
Issue number	12
DOIs	https://doi.org/10.1016/j.ekir.2019.08.010
State	Published - Dec 2019

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/j.ekir.2019.08.010

Cite this

Hanudel, M. R., Salusky, I. B., Pereira, R. C., Wang, W., You, Z., Nowak, K. L., Brosnahan, G. M., Torres, V. E., Chapman, A. B., Perrone, R. D., Steinman, T. I., Bae, K. T., Gitomer, B. Y., & Chonchol, M. B. (2019). Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients. Kidney International Reports, 4(12), 1742-1748. https://doi.org/10.1016/j.ekir.2019.08.010

Hanudel, MR, Salusky, IB, Pereira, RC, Wang, W, You, Z, Nowak, KL, Brosnahan, GM, Torres, VE, Chapman, AB, Perrone, RD, Steinman, TI, Bae, KT, Gitomer, BY & Chonchol, MB 2019, 'Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients', Kidney International Reports, vol. 4, no. 12, pp. 1742-1748. https://doi.org/10.1016/j.ekir.2019.08.010

@article{a870d07f22d3460fb611de4b2363aa8b,

title = "Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients",

author = "Hanudel, {Mark R.} and Salusky, {Isidro B.} and Pereira, {Renata C.} and Wei Wang and Zhiying You and Nowak, {Kristen L.} and Brosnahan, {Godela M.} and Torres, {Vicente E.} and Chapman, {Arlene B.} and Perrone, {Ronald D.} and Steinman, {Theodore I.} and Bae, {Kyongtae T.} and Gitomer, {Berenice Y.} and Chonchol, {Michel B.}",

note = "Funding Information: The work in this letter was performed with the support of the National Institute of Diabetes, Digestive, and Kidney Disease of the National Institutes of Health research grants R01-DK094796 (to BYG and MBC) and K08-DK111980 (to MRH). Funding Information: The work in this letter was performed with the support of the National Institute of Diabetes, Digestive, and Kidney Disease of the National Institutes of Health research grants R01-DK094796 (to BYG and MBC) and K08-DK111980 (to MRH). Research idea and study design: MRH, IBS, BYG, MBC; data acquisition: MRH, RCP, BYG; data analysis/interpretation: MRH, IBS, BYG, MBC; manuscript drafting: MRH; manuscript review and revision: MRH, IBS, RCP, WW, ZY, KLN, GMB, VET, ABC, RDP, TIS, KTB, BYG, MBC.",

year = "2019",

month = dec,

doi = "10.1016/j.ekir.2019.08.010",

language = "English (US)",

volume = "4",

pages = "1742--1748",

journal = "Kidney International Reports",

issn = "2468-0249",

publisher = "Elsevier Inc.",

number = "12",

}

TY - JOUR

T1 - Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients

AU - Hanudel, Mark R.

AU - Salusky, Isidro B.

AU - Pereira, Renata C.

AU - Wang, Wei

AU - You, Zhiying

AU - Nowak, Kristen L.

AU - Brosnahan, Godela M.

AU - Torres, Vicente E.

AU - Chapman, Arlene B.

AU - Perrone, Ronald D.

AU - Steinman, Theodore I.

AU - Bae, Kyongtae T.

AU - Gitomer, Berenice Y.

AU - Chonchol, Michel B.

N1 - Funding Information: The work in this letter was performed with the support of the National Institute of Diabetes, Digestive, and Kidney Disease of the National Institutes of Health research grants R01-DK094796 (to BYG and MBC) and K08-DK111980 (to MRH). Funding Information: The work in this letter was performed with the support of the National Institute of Diabetes, Digestive, and Kidney Disease of the National Institutes of Health research grants R01-DK094796 (to BYG and MBC) and K08-DK111980 (to MRH). Research idea and study design: MRH, IBS, BYG, MBC; data acquisition: MRH, RCP, BYG; data analysis/interpretation: MRH, IBS, BYG, MBC; manuscript drafting: MRH; manuscript review and revision: MRH, IBS, RCP, WW, ZY, KLN, GMB, VET, ABC, RDP, TIS, KTB, BYG, MBC.

PY - 2019/12

Y1 - 2019/12

UR - http://www.scopus.com/inward/record.url?scp=85075345888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075345888&partnerID=8YFLogxK

U2 - 10.1016/j.ekir.2019.08.010

DO - 10.1016/j.ekir.2019.08.010

M3 - Article

AN - SCOPUS:85075345888

SN - 2468-0249

VL - 4

SP - 1742

EP - 1748

JO - Kidney International Reports

JF - Kidney International Reports

IS - 12

ER -

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this